Semaglutide guidelines based on BMI may exclude at-risk Indians
Global semaglutide eligibility standards based on BMI may not replicate Indian threat patterns, probably excluding high-risk sufferers who develop heart problems at decrease physique weights |Image used for representational function solely | Photo Credit: AFP The SELECT trial, led by A. Michael Lincoff and published in The New England Journal of Medicine (2023), confirmed that…